Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

Holdings in Q3 2023

Holdings as of Sep 30, 2023, filed Nov 14, 2023. Long positions only; changes compare share counts with Q2 2023.

Institution overview
Positions
68
−4 vs. Q2 2023
Portfolio value
$2.10B
−$503.7M (−19.3%) vs. Q2 2023
Filed
Nov 14, 2023
SEC
Holdings of Redmile Group, LLC in Q3 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
IMGNImmunoGen, Inc.COM17,503,417$277.8M13.2%−227,000−1.3%ReducedHistory
KRYSKrystal Biotech, Inc.COM2,003,367$232.4M11.1%−563,294−21.9%ReducedHistory
FOLDAmicus Therapeutics, Inc.COM16,944,621$206.0M9.8%−2,622,340−13.4%ReducedHistory
AKROAkero Therapeutics, Inc.COM1,769,684$89.5M4.3%−41,988−2.3%ReducedHistory
AUGXAugmedix, Inc.COM15,630,327$80.5M3.8%00.0%UnchangedHistory
REPLReplimune Group, Inc.COM4,163,922$71.2M3.4%−256,611−5.8%ReducedHistory
LIVNLivaNova PLCSHS1,100,492$58.2M2.8%00.0%UnchangedHistory
DCPHDeciphera Pharmaceuticals, Inc.COM4,475,384$56.9M2.7%−403,182−8.3%ReducedHistory
PLRXPliant Therapeutics, Inc.COM2,678,099$46.4M2.2%00.0%UnchangedHistory
CLDXCelldex Therapeutics, Inc.COM NEW1,635,938$45.0M2.1%−60,066−3.5%ReducedHistory
RGNXREGENXBIO Inc.COM2,574,042$42.4M2.0%+547,466+27.0%AddedHistory
IMVTImmunovant, Inc.COM1,102,514$42.3M2.0%−818,638−42.6%ReducedHistory
RYZBRayzeBio, Inc.COM1,857,706$41.2M2.0%+1,857,706NewHistory
BSXBoston Scientific CorpStock774,200$40.9M1.9%+383,022+97.9%AddedHistory
CTLTCatalent, Inc.COM873,966$39.8M1.9%−288,200−24.8%ReducedHistory
PENPenumbra IncCOM155,076$37.5M1.8%+16,106+11.6%AddedHistory
ELVElevance Health, Inc.Stock85,378$37.2M1.8%+7,065+9.0%AddedHistory
ZYMEZymeworks Inc.COM5,661,230$35.9M1.7%00.0%UnchangedHistory
BEAMBeam Therapeutics Inc.COM1,469,725$35.3M1.7%−15,474−1.0%ReducedHistory
SRRKScholar Rock Holding CorpCOM4,733,248$33.6M1.6%+329,408+7.5%AddedHistory
VTYXVentyx Biosciences, Inc.COM929,900$32.3M1.5%−10,593−1.1%ReducedHistory
HUMHumana IncStock59,851$29.1M1.4%+13,541+29.2%AddedHistory
RPTXRepare Therapeutics Inc.COM2,404,695$29.0M1.4%−23,640−1.0%ReducedHistory
FATEFate Therapeutics IncCOM13,124,427$27.8M1.3%00.0%UnchangedHistory
CABACabaletta Bio, Inc.COM1,774,252$27.0M1.3%+403,953+29.5%AddedHistory
KYMRKymera Therapeutics, Inc.COM1,868,507$26.0M1.2%00.0%UnchangedHistory
SYKStryker CorpStock94,738$25.9M1.2%+8,839+10.3%AddedHistory
IGMSIGM Biosciences, Inc.COM2,971,542$24.8M1.2%00.0%UnchangedHistory
DXCMDexcom IncCOM244,391$22.8M1.1%−44,770−15.5%ReducedHistory
NRIXNurix Therapeutics, Inc.COM2,848,827$22.4M1.1%−8,482−0.3%ReducedHistory
TRDAEntrada Therapeutics, Inc.COM1,284,000$20.3M1.0%−27,572−2.1%ReducedHistory
COGTCogent Biosciences, Inc.COM2,053,333$20.0M1.0%00.0%UnchangedHistory
STOKStoke Therapeutics, Inc.COM3,872,696$15.3M0.7%−82,492−2.1%ReducedHistory
GRTSGritstone bio, Inc.COM8,509,126$14.6M0.7%+1,648,900+24.0%AddedHistory
XENEXenon Pharmaceuticals Inc.COM419,568$14.3M0.7%−700,908−62.6%ReducedHistory
BHVNBiohaven Ltd.COM518,924$13.5M0.6%+518,924NewHistory
CRLCharles River Laboratories International, Inc.COM66,382$13.0M0.6%−47,969−41.9%ReducedHistory
ADCTADC Therapeutics SASHS14,178,045$12.7M0.6%+128,110+0.9%AddedHistory
EVHEvolent Health, Inc.CL A465,282$12.7M0.6%+251,850+118.0%AddedHistory
PRMEPrime Medicine, Inc.COM1,324,350$12.6M0.6%00.0%UnchangedHistory
ETNB89bio, Inc.COM761,955$11.8M0.6%00.0%UnchangedHistory
VERVVerve Therapeutics, Inc.COM809,777$10.7M0.5%−252,183−23.7%ReducedHistory
ABSIAbsci CorpCOM8,031,094$10.6M0.5%00.0%UnchangedHistory
ALLKAllakos Inc.COM4,135,061$9.39M0.4%+1,851,467+81.1%AddedHistory
ATRAAtara Biotherapeutics, Inc.COM6,280,813$9.30M0.4%+232,690+3.8%AddedHistory
STXSStereotaxis, Inc.COM NEW5,765,792$9.11M0.4%−608,106−9.5%ReducedHistory
STTKShattuck Labs, Inc.COM5,619,914$8.54M0.4%00.0%UnchangedHistory
ANNXAnnexon, Inc.COM3,503,190$8.27M0.4%00.0%UnchangedHistory
SNCEScience 37 Holdings, Inc.COM19,808,234$7.92M0.4%00.0%UnchangedHistory
RAPTRAPT Therapeutics, Inc.COM427,490$7.10M0.3%−4,429−1.0%ReducedHistory
ALXOAlx Oncology Holdings IncCOM1,283,289$6.16M0.3%00.0%UnchangedHistory
HCAHCA Healthcare, Inc.COM24,667$6.07M0.3%+24,667NewHistory
MDVLMedAvail Holdings, Inc.COM NEW692,082$4.19M0.2%00.0%UnchangedConverted for a 1-for-50 splitHistory
KLRSKalaris Therapeutics, Inc.COM1,907,969$4.10M0.2%00.0%UnchangedHistory
NUVBNuvation Bio Inc.COM CL A3,031,009$4.06M0.2%00.0%UnchangedHistory
LVTXLAVA Therapeutics NVSHS2,074,372$3.09M0.1%00.0%UnchangedHistory
IVVDInvivyd, Inc.COM1,440,725$2.45M0.1%00.0%UnchangedHistory
NGNENeurogene Inc.COM NEW582,443$2.30M0.1%00.0%UnchangedConverted for a 1-for-5 splitHistory
CUTRCutera IncCOM334,996$2.02M0.1%+334,996NewHistory
XERSXeris Biopharma Holdings, Inc.COM1,046,587$1.95M0.1%00.0%UnchangedHistory
Achilles Therapeutics PLC00449L102SPONSORED ADS1,608,089$1.46M0.1%00.0%Unchanged–
NVTAInvitae CorpCOM2,280,403$1.38M0.1%00.0%UnchangedHistory
SLGCSomaLogic, Inc.CLASS A COM399,439$954.7K<0.1%−1,471,400−78.6%ReducedHistory
TKNOAlpha Teknova, Inc.COM284,564$793.9K<0.1%−24,288−7.9%ReducedHistory
HOOKHOOKIPA Pharma Inc.COM1,063,769$655.3K<0.1%−2,224,700−67.7%ReducedHistory
ADAPYAdaptimmune Therapeutics PLCSPONDS ADR715,607$558.2K<0.1%00.0%UnchangedHistory
SONXSonendo, Inc.COM410,393$306.1K<0.1%−87,738−17.6%ReducedHistory
BCELAtreca, Inc.CL A COM442,653$115.5K<0.1%00.0%UnchangedHistory

Sold out since Q2 2023 (8)

Positions held at the end of Q2 2023 that are gone from this filing.

Positions of Redmile Group, LLC sold out since Q2 2023
SecurityClassShares in Q2 2023Value in Q2 2023% of portfolio in Q2 2023History
BMRNBiomarin Pharmaceutical IncCOM489,208$42.4M1.6%History
JAZZJazz Pharmaceuticals plcSHS USD341,882$42.4M1.6%History
ZBHZimmer Biomet Holdings, Inc.Stock151,372$22.0M0.8%History
IQVIQVIA Holdings Inc.Stock94,409$21.2M0.8%History
SLRNACELYRIN, Inc.COM364,493$7.62M0.3%History
STVNStevanato Group S.p.A.ORD SHS218,169$7.06M0.3%History
MRSNMersana Therapeutics, Inc.COM1,698,626$5.59M0.2%History
GRFSGrifols SASP ADR REP B NVT600,684$5.50M0.2%History